Biotech Start-Up Talking20 to Provide DTC Proteomic and Metabolomic Testing | GenomeWeb

While the last decade saw the rise – and sometimes fall – of a number of direct-to-consumer genomics firms, including 23andMe, Navigenics, and Decode Genetics, the market for DTC proteomics has remained largely unexplored.

A new DTC proteomics and metabolomics firm hopes to change that. San Francisco-based Talking20 launched two weeks ago at the Open Science Summit in Mountain View, Calif. Since then the company has sold several hundred kits to interested users, founder and CEO Heather Heine told ProteoMonitor.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.